IFN-α in Relapse Prevention.
NCT07449286
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Acute Myeloid Leukemia
Myelodysplastic Syndromes
Interventions
DRUG:
IFN-α
Sponsor
Peking University People's Hospital
Collaborators
[object Object]
[object Object]
[object Object]
[object Object]